SCHEMBL6420010

SCHEMBL6420010

PC1c2ccccc2C=Cc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.50
KDM4E B2RXH2 5/20 0.39
CYP2D6 P10635 3/20 0.39
HSD17B10 Q99714 3/20 0.39
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
LMNA P02545 2/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
NFKB1 P19838 1/20 0.39
CHRM3 P20309 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
THPO P40225 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18930074 0.74 HTR2A (0.41) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL7869538 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL8036851 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL10080430 0.72 HTR2A (0.56) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL11875463 0.72 BRD4 (0.53) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL1276091 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL5679950 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL31099344 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL4108490 0.71 GPR3 (0.46) HTR2ACYP2D6CHRM2CHRM1SLC6A2
SCHEMBL24475199 0.70 MEN1 (0.33) HTR2AMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107608-A1 Ligands for use in catalytic processes EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH ETHZ (CH) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107608-A1 Ligands for use in catalytic processes PNKP, ITPA, PLCG2 HTR2A 4161/4885KDM4E 3430/4885CYP2D6 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.